Jefferies Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $150
BioNTech Is Maintained at Neutral by JP Morgan
BioNTech Analyst Ratings
J.P. Morgan Maintains BioNTech(BNTX.US) With Hold Rating, Cuts Target Price to $124
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX)
CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $171
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
BioNTech Is Maintained at Hold by TD Cowen
BioNTech Analyst Ratings
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
TD Cowen Maintains BioNTech(BNTX.US) With Hold Rating, Raises Target Price to $132
Cautious Long-term Growth Potential: Yaron Werber's Hold Rating on BioNTech SE
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
HSBC Initiates BioNTech(BNTX.US) With Buy Rating, Announces Target Price $136
BioNTech Is Maintained at Buy by HSBC
Morgan Stanley Upgrades BioNTech(BNTX.US) to Buy Rating, Raises Target Price to $145
BioNTech Analyst Ratings
No Data
No Data